CASELLI, Michele
 Distribuzione geografica
Continente #
NA - Nord America 10.340
AS - Asia 6.151
EU - Europa 3.973
SA - Sud America 980
Continente sconosciuto - Info sul continente non disponibili 146
AF - Africa 116
OC - Oceania 11
Totale 21.717
Nazione #
US - Stati Uniti d'America 10.061
SG - Singapore 2.278
CN - Cina 1.598
DE - Germania 1.169
BR - Brasile 773
IT - Italia 685
UA - Ucraina 651
VN - Vietnam 636
HK - Hong Kong 519
TR - Turchia 512
RU - Federazione Russa 334
GB - Regno Unito 299
FI - Finlandia 248
FR - Francia 214
JP - Giappone 151
CA - Canada 135
SE - Svezia 124
BD - Bangladesh 112
MX - Messico 104
IN - India 97
AR - Argentina 80
NL - Olanda 61
ZA - Sudafrica 54
PL - Polonia 46
IQ - Iraq 35
ID - Indonesia 34
EC - Ecuador 33
ES - Italia 32
CO - Colombia 26
UZ - Uzbekistan 25
MY - Malesia 23
CL - Cile 21
PK - Pakistan 21
BE - Belgio 18
CZ - Repubblica Ceca 17
PH - Filippine 16
PY - Paraguay 16
LT - Lituania 15
TN - Tunisia 13
JM - Giamaica 12
JO - Giordania 12
VE - Venezuela 12
IE - Irlanda 11
MA - Marocco 11
SA - Arabia Saudita 11
AU - Australia 9
AE - Emirati Arabi Uniti 8
IL - Israele 8
PE - Perù 8
AT - Austria 7
CH - Svizzera 7
DZ - Algeria 7
EU - Europa 7
PT - Portogallo 7
TH - Thailandia 7
CR - Costa Rica 6
EG - Egitto 6
KZ - Kazakistan 6
HN - Honduras 5
KE - Kenya 5
NP - Nepal 5
OM - Oman 5
RO - Romania 5
AZ - Azerbaigian 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GR - Grecia 4
NI - Nicaragua 4
UY - Uruguay 4
AM - Armenia 3
BG - Bulgaria 3
BY - Bielorussia 3
GT - Guatemala 3
KR - Corea 3
LY - Libia 3
RE - Reunion 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
BH - Bahrain 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GY - Guiana 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
PS - Palestinian Territory 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
GE - Georgia 1
GH - Ghana 1
GI - Gibilterra 1
Totale 21.561
Città #
Singapore 1.456
Ashburn 1.024
San Jose 830
Woodbridge 815
Jacksonville 738
Fairfield 697
Chandler 561
Santa Clara 560
Houston 537
Beijing 533
Hong Kong 511
Ann Arbor 329
Council Bluffs 314
Seattle 261
Wilmington 258
Izmir 251
Ho Chi Minh City 216
Nanjing 213
Cambridge 200
New York 183
Hanoi 161
Los Angeles 154
Tokyo 149
Princeton 134
Lauterbourg 119
Milan 106
Munich 105
Dallas 97
Addison 89
São Paulo 85
Helsinki 77
Moscow 72
San Diego 72
Shanghai 70
Shenyang 68
Mexico City 64
Nanchang 57
Orem 53
Tianjin 53
Changsha 46
Montreal 43
Toronto 42
Jiaxing 40
Buffalo 39
Chicago 39
Hebei 38
Turku 37
Rome 35
Warsaw 35
Atlanta 34
Ferrara 34
London 33
Boardman 30
Chennai 30
Dearborn 30
Phoenix 30
Brooklyn 29
Da Nang 27
Rio de Janeiro 27
San Francisco 27
Bologna 26
Poplar 25
Haiphong 23
Zhengzhou 23
Naples 22
Tashkent 22
Denver 21
Johannesburg 21
Verona 21
Washington 21
Frankfurt am Main 20
Norwalk 20
Stockholm 20
Amsterdam 19
Bremen 19
Guangzhou 19
Jinan 19
Boston 18
Manchester 18
Belo Horizonte 17
Baghdad 16
Kuala Lumpur 16
Orange 16
Auburn Hills 15
Hải Dương 15
Kunming 15
Hefei 14
Ningbo 14
Ankara 13
Brussels 13
Charlotte 13
Curitiba 13
Eygelshoven 12
Newark 12
Turin 12
Amman 11
Brasília 11
Campinas 11
Falkenstein 11
Guayaquil 11
Totale 13.675
Nome #
Ruolo dei batteri componenti la flora intestinale nell'eziopatogenesi della colite ulcerosa e del cancro del colon: i Fusobatteri e il Bacterioides fragilis enterotossico prendono la scena 476
"Cervia Working Group Report": Guidelines on the diagnosis and treatment of Helicobacter pylori infection 264
A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection 258
Dead fecal yeasts and chronic diarrhea 255
A possible role of food intolerance in the pathogenesis of gastroesophageal reflux disease 254
Actual concept of "probiotics": is it more functional to science or business? 247
Cholesterol vesicles in areas of gastric metaplasia of Gallbladder Epithelium 245
Touch cytology. A reliable and cost-effective method for diagnosis of Helicobacter pylori infection 245
Bacterial adhesion and Helicobacter pylori 240
Structural Bacterial Molecules as Potential Candidates for an Evolution of the Classical Concept of Probiotics 234
Prophylaxis and treatment of NSAID-induced gastroduodenal disorders 232
Evaluation of a new ultrashort triple therapy for Helicobacter pylori disease 232
Histologic findings and Helicobacter pylori in duodenal biopsies 231
Fhit protein expression in human gastric cancer and related precancerous lesions 229
Gastric metaplasia in duodenal bulb and Campylobacter-like organisms in development of duodenal ulcer 222
Campylobacter pylori and gastric mucosa 218
Gastric metaplasia of the duodenal bulb. 216
Helicobacter pylori and intestinal metaplasia: Possible implications in gastric carcinogenesis [7] 211
An Italian consensus on duodenitis and Helicobacter pylori 210
Evaluation of a new enzyme immunoassay for detecting Helicobacter pylori in feces: a prospective pilot study 210
Campylobacter-like organisms, nonsteroidal anti-inflammatory drugs and gastric lesions in patients with rheumatoid arthritis 210
Migraine in children and Helicobacter pylori. 209
Helicobacter pylori and human leukocyte antigens [2] 209
Blastocystis hominis: a neglected cause of diarrhoea? 208
Ultrastructural patterns of Helicobacter pylori 201
Epithelial morphology of duodenal bulb and Campylobacter-like organisms 198
Irritable bowel syndrome. 195
Endoscopic aspects of gastroduodenal mucosa due to NSAIDs 194
Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori 191
Segmented filamentous bacteria-like organisms in histological slides of ileo-cecal valves in patients with ulcerative colitis 191
Gall bladder epithelium and cholesterol gall stones 188
Migraine in children and Helicobacter pylori 187
Helicobacter pylori and Non-Steroidal Anti-Inflammatory Drugs 186
A comparative trial of short term therapy with omeprazole plus either amoxycillin or azithromycin for Helicobacter pylori eradication 185
Usefulness of brushing urease test for diagnosis of Helicobacter pylori infection. 184
Helicobacter pylori and chronic bronchitis 182
Blastocystis hominis and diarrhoea 182
Characteristics of polyphosphate granules of Helicobacter pylori. 180
Terminology and gastric epithelial dysplasia 179
Biochemical rapid tests for the diagnosis of Campylobacter pylori in endoscopy rooms 179
Cholesterol vesicles in areas of gastric metaplasia of gallbladder epthelium. 178
PCR detection of segmented filamentous bacteria in the terminal ileum of patients with ulcerative colitis 178
Omeprazole and an ranitidine in the prevention of 5-Fluoruracil-induced gastroduodenal injury. 176
Histological findings in gastric mucosa in patients treated with non-steroidal anti-inflammatory drugs 175
Sydney classification for gastritis and Helicobacter pylori 175
Campylobacter pyloridis e malatia peptica gastro-duodenale. 173
Reflux Symptoms in Professional Opera Choristers 171
Suggestions for the rapid diagnosis of Campylobacter pylori infection in endoscopic settings 170
Ultra-short triple therapy for eradication of Helicobacter pylori. 170
Localized gastric amyloidosis. Clinico-radiologic aspects 169
Helicobacter pylori and peptic-ulcer disease. 169
Cholesterol vesicles in areas of gastric metaplasia of gallbladder ephitelium. 168
Detection of Helicobacter pylori in faeces with a new enzyme immunoassay method: preliminary results. 167
Do nonsteroidal anti-inflammatory drugs have a protective effect against Campylobacter pylori? 167
Diagnosis of Helicobacter pylori infection by HpSA test. 166
Ultrastructural patterns of Helicobacter pylori. 166
Test-based exclusion diets in gastro-esophageal reflux disease patients: A randomized controlled pilot trial 166
"Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. 166
Electrical hazards in endoscopic services 165
Patterns of Physical Modes of Contact between Campylobacter pylori and Gastric Epithelium: Implications about the Bacterial Pathogenicity 165
Morphology of segmented filamentous bacteria and their patterns of contact with the follicle-associated epithelium of the mouse terminal ileum implications for the relationship with the immune system 164
Gastric apoptosis and Helicobacter pylori infection: An intricate matter 163
HLA molecular alleles, chronic gastritis and Helicobacter pylori. 160
Tumorigenesi gastrica Helicobacter pylori correlata. 160
Cholesterol vesicles in areas of gastric metaplasia of gallbladder epthelium. 160
Adhesion of helicobacter pylori in both gastric gastric antrum and duodenal bulb. 156
Rectal infusion of bacterial preparation for intestinal disorders. 155
Campylobacter pylori and gastric mucosa. What method to use in the diagnosis? 155
Ultrasonic demonstration of small thyroid nodules. 155
Campylobacter pyloridis : un nuovo agente per una vecchia malattia. 154
Helicobacter priori stool antigen test: Clinical evaluation and cost analysis of a new enzyme immunoassay 153
Ultrastructural damage of gastric epithelium in patients taking NSAIDs 153
Rapid urease test on cytological brushing: a fast test for detectin Helicobacter pylori infection. 153
Relation of Helicobacter pylori infection and coronary heart disease. 152
Capitolo 14. 151
Helicobacter pylori-related duodenitis. 150
Papillosfinterotomia perendoscopica. 149
Il ruolo biologico del Campylobacter pylori nelle patologie gastroduodenali. 148
Two unusual techiques for diagnosing Helicobacter pylori infection. 148
Congress report 146
Stool test with polyclonal antibodies for monitoring Helicobacter pylori eradication in adults: A critical reappraisal 145
Ultrasonic differentiation between mucocele and empyema of gallbladder. 142
Lansoprazole in gastric juice. 141
Test bichimiques d'identification du Campylobacter pylori en endoscopie pratique au cabinet médical. 141
Recrudescienza e reinfezione da Helicobacter pylori. 139
Pathogenetic classification if chronic gastritis 138
Therapy of NSAIDs-induced gastropathy 138
Looking for new anti-Helicobacter pylori regimens. The right time for a little break ? 138
Rapid identification of Campylobacter pylori by endoscopical brushing. 138
EPITHELIAL DAMAGE CAUSED BY HELICOBACTER-PYLORI AND NONSTEROIDAL ANTIINFLAMMATORY DRUGS 138
Helicobacter pylori and heart. 137
Profilaxis and treatment of NSAID-induced gastroduodenal disorders 135
Histological aspects of gastric mucosal damage due to NSAId and H. pylori. 135
Patterns of gatsric hepitelial cell damage associated with Helicobacter pylori infection 133
Capitolo 1 133
Helicobacter pylori in the duodenal bulb. 133
Gastrite: l'observation endoscopique est elle suffisante pour formuler le diagnostique? 130
Gallbladder volume assesment in healthy subjects: sonographic study. 129
Malaria del vaggiatore: Contributo clinico-epidemiologico. 129
Zinco e AIDS. 127
Totale 17.971
Categoria #
all - tutte 92.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.061
Totale 97.044


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.205 0 113 36 141 95 30 34 104 55 104 136 357
2022/20231.190 157 28 45 122 156 223 21 135 181 13 58 51
2023/2024806 76 110 37 29 65 180 26 48 14 21 22 178
2024/20252.684 60 59 209 52 332 365 38 121 361 416 338 333
2025/20267.860 773 386 622 1.110 1.326 581 827 348 724 775 286 102
2026/2027637 222 415 0 0 0 0 0 0 0 0 0 0
Totale 21.717